Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

Health care values look high

Analyst forecasts suggest that healthcare sector valuations have been largely unaffected by the crisis, with EMEA hospitals and medtech stocks now being more expensive than before the Covid outbreak, both on an EBITDA and PE multiples basis.

Exclusive: Steward’s International CEO on its future in Malta

Now that Steward Health Care has been bought by its doctors, what future does it face in Malta where the deal it inherited to run almost half the country’s public hospitals had attracted scrutiny? HBI talks exclusively to Dr Armin Ernst, CEO and President of Steward Health Care International.

Case study: Denmark’s informal and formal telemedicine market

How many doctors are using Skype and other vanilla, publicly available platforms and how many are adopting built for purpose telehealth solutions?  This Danish data gives some indication of the likely split between the only officially recommended solution and what are likely to be vanilla, publicly available platforms. The Danish doctors union has historically been […]

Aster shows Covid impact on India and GCC

Thanks to Covid, Aster DM, the GCC to India clinic, hospital and pharmacy chain, saw a 25% drop in revenue across both geographies in April. May and June have seen improvements with a return to normal expected in the autumn, providing there is no second wave. We look in detail at the impact of Covid in March to June and report full year results to March 2020.

Could Synlab’s UK success open the outsourcing floodgates?

UK lab group Viapath has been nationalised, after Guy's and St Thomas' and King's College Hospital NHS Foundation Trusts bought out its private sector partner Serco following the loss of a £2.25bn outsourcing contract in which Synlab remains the preferred bidder. Could Synlab's expected success be the first of a slew of new outsourcing contracts for big lab platforms? HBI talks to a consultant to find out more.

Find Us